<p>The present invention relates to the use of at least one attenuated measles virus for the manufacture of a medicament intended for treating malignant mesothelioma in an individual.</p>
申请公布号
EP2058003(A1)
申请公布日期
2009.05.13
申请号
EP20070291232
申请日期
2007.10.10
申请人
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);INSTITUT PASTEUR
